ICR Reveals New Courses on EU Regulation & Line Management
ICR has announced two new courses for December 2014 about the impact of the European Union regulation and essential line management.
The Institute of Clinical Research (ICR) has announced two new courses for December 2014 about the impact of the European Union regulation and essential line management. The former event is scheduled for December 9, while the latter will take place on December10-11.
Other eye-catching training sessions being organized by ICR are on skills and competencies of a clinical trials manager (October 9-10), effective clinical trial management (November 11-13), and essentials of clinical trials monitoring (November 25).
ICR is a not-for-profit organization that provides education and training, conferences and networking events, and news updates and analysis on all aspects of clinical research. Members are engaged in all aspects of work in clinical research, both directly and in the support services. It was founded in 1978 as ACRPI (Association of Clinical Research for the Pharmaceutical Industry), and changed its name to ICR in 2000. Its head office is in Maidenhead, Berkshire, U.K., and it has over 3000 members in 49 countries around the world.
For further details, contact icrenquiries@yahoo.co.uk or visit http://www.icr-global.org/home/.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
